Agilent Technologies to introduce genomics technology into India's growing life sciences market
Agilent Technologies Inc. announced plans to introduce its DNA microarray-based genomics solutions into India's growing life sciences market. Agilent currently sells technologies for the chemical, environmental and pharmaceutical manufacturing markets in India, and is a biotech leader there. The company expects to expand its presence into industries such as medical research, drug discovery and agro-biotech.
"Agilent's Life Sciences and Chemical Analysis business had double-digit growth in India last year, driven by the country's booming biotechnology, agriculture, information technology and pharmaceuticals industries," said Sanjeev Dhar, country manager for the LSCA business in India. "India is now LSCA's fourth-largest country of business in Asia, and one of the fastest-growing. We expect this growth to continue as we launch our industry-leading solutions for the life sciences sector into areas such as genomics and proteomics research."
The Indian microarray market is estimated to grow by approximately 70 percent in 2005, according to genomics and bioinformatics company Genotypic.
Agilent's life science technologies address demand from government-funded research institutions and pharmaceutical companies -- a demand expected to be fueled by the Indian government's Draft National Biotechnology Policy. The strategy focuses on using biotechnology as a tool to improve quality of life and aims to position India as a worldwide hub for biotechnology research. A government-supported infrastructure is expected to stimulate research in areas such as genomics, stem cells, molecular medicine, metabolic engineering and cell biology.
Agilent Technologies Inc. announced it has acquired Oxfordshire, U.K.-based Cobalt Light Systems, a provider of highly differentiated Raman spectroscopic instruments for the pharmaceutical industry, applied markets and public safety. Cobalt’s innovative suite of benchtop and handheld/porta ... more
Agilent Technologies Inc. and Agendia, Inc. today jointly announced an agreement to expand their relationship to include the development of an RNASeq kit version of Agendia’s currently marketed MammaPrint and BluePrint tests. Agendia’s MammaPrint test provides High-Risk or Low-Risk test re ... more
Agilent Technologies announced that it received three awards at the Annual Conference of China Scientific Instruments (ACCSI) 2017 in Nanjing, China. Agilent received the following awards: Green Product of the Year, Most Popular Scientific Instrument, and Most Influential Foreign Manufactu ... more
The Agilent 6495 Triple Quadrupole LC/MS system incorporates proven iFunnel Technology and innovative ion optics and detector design for ultra-trace analysis – with low attogram limits of quantitation, excellent assay precision and accuracy, and wide dynamic range for your most demanding as ... more
Agilent Technologies Inc. announced that it has signed five distributors to sell and distribute genomics products for microarray analysis. The distributors service India, Indonesia, Korea, Hong Kong, China and Australia. In addition, Agilent has expanded its Certified Service Provider netwo ... more
Agilent Technologies Inc. announced plans to introduce its DNA microarray-based genomics solutions into India's growing life sciences market. Agilent currently sells technologies for the chemical, environmental and pharmaceutical manufacturing markets in India, and is a biotech leader there ... more